Thymuline (Ratis, LLC)


Welcome to the PulseAid listing for the Thymuline drug offered from Ratis, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Ratis, LLC
NON-PROPRIETARY NAME: Thymuline
SUBSTANCE NAME: NONATHYMULIN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-10-03
END MARKETING DATE: 0000-00-00


Thymuline HUMAN OTC DRUG Details:

Item DescriptionThymuline from Ratis, LLC
LABELER NAME: Ratis, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 9([hp_C]/mL)
START MARKETING DATE: 2017-10-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71753-1052_60c17036-3893-4545-9d60-7d7dd5031dda
PRODUCT NDC: 71753-1052
APPLICATION NUMBER:

Other NONATHYMULIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Ratis, LLCThymuline